Status:
COMPLETED
Ibuprofen/Acetaminophen Versus Nurofen Plus® and Panadeine® Extra Dental Pain Study
Lead Sponsor:
Reckitt Benckiser LLC
Collaborating Sponsors:
Premier Research
Aptuit
Conditions:
Post-operative Pain
Eligibility:
All Genders
16+ years
Phase:
PHASE3
Brief Summary
The objective is to assess the efficacy and tolerability of a combination of 400 mg ibuprofen plus 1000 mg acetaminophen, 200 mg ibuprofen plus 500 mg acetaminophen compared with Nurofen Plus® and Pan...
Detailed Description
RB has developed a fixed-dose combination of ibuprofen and acetaminophen (paracetamol). Since the pharmacological actions of ibuprofen and acetaminophen (paracetamol) differ in their site and mode of ...
Eligibility Criteria
Inclusion
- Main
- Experiencing moderate to severe pain after extraction of impacted third molars
- Main
Exclusion
- Any ongoing painful condition other than that associated with the current third molar surgery that could significantly interfere with the subject's suitability Any condition that would render the subject unsuitable to receive an NSAID, acetaminophen or codeine
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
678 Patients enrolled
Trial Details
Trial ID
NCT01229449
Start Date
January 1 2009
End Date
September 1 2009
Last Update
September 17 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Premier Research
Austin, Texas, United States, 78705